Annual gross profit:
$27.98B+$1.57B(+5.93%)Summary
- As of today (August 18, 2025), GSK annual gross profit is $27.98 billion, with the most recent change of +$1.57 billion (+5.93%) on December 31, 2024.
- During the last 3 years, GSK annual gross profit has risen by +$5.51 billion (+24.50%).
- GSK annual gross profit is now -19.25% below its all-time high of $34.65 billion, reached on December 31, 2007.
Performance
GSK Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$7.78B+$735.67M(+10.45%)Summary
- As of today (August 18, 2025), GSK quarterly gross profit is $7.78 billion, with the most recent change of +$735.67 million (+10.45%) on June 30, 2025.
- Over the past year, GSK quarterly gross profit has increased by +$453.39 million (+6.19%).
- GSK quarterly gross profit is now -29.78% below its all-time high of $11.07 billion, reached on June 30, 2008.
Performance
GSK quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$29.36B+$453.39M(+1.57%)Summary
- As of today (August 18, 2025), GSK TTM gross profit is $29.36 billion, with the most recent change of +$453.39 million (+1.57%) on June 30, 2025.
- Over the past year, GSK TTM gross profit has increased by +$1.26 billion (+4.47%).
- GSK TTM gross profit is now -24.93% below its all-time high of $39.10 billion, reached on September 30, 2008.
Performance
GSK TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
GSK Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.9% | +6.2% | +4.5% |
| 3 y3 years | +24.5% | +29.8% | +21.1% |
| 5 y5 years | -4.2% | +20.8% | +0.1% |
GSK Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.5% | at high | +29.8% | at high | +21.3% |
| 5 y | 5-year | -5.6% | +24.5% | at high | +34.0% | -0.8% | +22.0% |
| alltime | all time | -19.3% | +871.3% | -29.8% | +187.0% | -24.9% | +983.6% |
GSK Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $7.78B(+10.5%) | $29.36B(+1.6%) |
| Mar 2025 | - | $7.04B(-1.6%) | $28.90B(+0.6%) |
| Dec 2024 | $27.98B(+5.9%) | $7.15B(-3.2%) | $28.74B(+2.5%) |
| Sep 2024 | - | $7.39B(+0.9%) | $28.04B(-0.2%) |
| Jun 2024 | - | $7.32B(+6.4%) | $28.10B(+2.7%) |
| Mar 2024 | - | $6.88B(+6.6%) | $27.36B(+2.8%) |
| Dec 2023 | $26.42B(+10.2%) | $6.45B(-13.4%) | $26.61B(+1.4%) |
| Sep 2023 | - | $7.45B(+13.1%) | $26.23B(+4.3%) |
| Jun 2023 | - | $6.58B(+7.4%) | $25.16B(+2.4%) |
| Mar 2023 | - | $6.13B(+0.9%) | $24.56B(+0.4%) |
| Dec 2022 | $23.97B(+6.7%) | $6.08B(-4.6%) | $24.47B(+1.1%) |
| Sep 2022 | - | $6.37B(+6.3%) | $24.20B(-0.2%) |
| Jun 2022 | - | $5.99B(-0.8%) | $24.25B(+0.8%) |
| Mar 2022 | - | $6.03B(+3.9%) | $24.06B(-3.3%) |
| Dec 2021 | $22.48B(-24.2%) | $5.81B(-9.5%) | $24.88B(-6.8%) |
| Sep 2021 | - | $6.42B(+10.6%) | $26.69B(-4.4%) |
| Jun 2021 | - | $5.80B(-15.4%) | $27.92B(-2.2%) |
| Mar 2021 | - | $6.86B(-10.0%) | $28.56B(-3.5%) |
| Dec 2020 | $29.65B(+1.6%) | $7.61B(-0.5%) | $29.61B(+1.1%) |
| Sep 2020 | - | $7.65B(+18.8%) | $29.28B(-0.2%) |
| Jun 2020 | - | $6.44B(-18.5%) | $29.33B(-1.6%) |
| Mar 2020 | - | $7.90B(+8.5%) | $29.79B(+3.6%) |
| Dec 2019 | $29.20B(+4.6%) | $7.28B(-5.4%) | $28.75B(+1.7%) |
| Sep 2019 | - | $7.70B(+11.6%) | $28.27B(+2.1%) |
| Jun 2019 | - | $6.90B(+0.6%) | $27.68B(+0.4%) |
| Mar 2019 | - | $6.86B(+0.8%) | $27.58B(+0.5%) |
| Dec 2018 | $27.90B(+7.9%) | $6.81B(-4.2%) | $27.44B(+0.2%) |
| Sep 2018 | - | $7.11B(+4.6%) | $27.37B(+1.2%) |
| Jun 2018 | - | $6.80B(+1.1%) | $27.05B(+3.0%) |
| Mar 2018 | - | $6.72B(-0.3%) | $26.27B(+2.7%) |
| Dec 2017 | $25.87B(+4.3%) | $6.74B(-0.7%) | $25.59B(+1.9%) |
| Sep 2017 | - | $6.79B(+12.8%) | $25.11B(+0.9%) |
| Jun 2017 | - | $6.02B(-0.3%) | $24.88B(-1.3%) |
| Mar 2017 | - | $6.04B(-3.6%) | $25.20B(+0.6%) |
| Dec 2016 | $24.81B(+8.2%) | $6.26B(-4.7%) | $25.04B(+5.9%) |
| Sep 2016 | - | $6.57B(+3.6%) | $23.65B(+1.4%) |
| Jun 2016 | - | $6.34B(+7.8%) | $23.32B(+0.7%) |
| Mar 2016 | - | $5.88B(+20.8%) | $23.16B(+1.0%) |
| Dec 2015 | $22.93B(-10.5%) | $4.87B(-22.1%) | $22.94B(-7.7%) |
| Sep 2015 | - | $6.24B(+1.2%) | $24.84B(-0.8%) |
| Jun 2015 | - | $6.17B(+9.1%) | $25.05B(-1.6%) |
| Mar 2015 | - | $5.66B(-16.5%) | $25.46B(-3.2%) |
| Dec 2014 | $25.62B(-10.6%) | $6.77B(+5.0%) | $26.30B(-2.6%) |
| Sep 2014 | - | $6.45B(-1.9%) | $27.00B(-2.0%) |
| Jun 2014 | - | $6.58B(+1.3%) | $27.56B(-2.2%) |
| Mar 2014 | - | $6.50B(-13.1%) | $28.19B(-1.8%) |
| Dec 2013 | $28.67B(-2.9%) | $7.47B(+6.5%) | $28.69B(+0.4%) |
| Sep 2013 | - | $7.02B(-2.6%) | $28.57B(-0.7%) |
| Jun 2013 | - | $7.20B(+2.9%) | $28.78B(-0.6%) |
| Mar 2013 | - | $7.00B(-4.8%) | $28.97B(-2.0%) |
| Dec 2012 | $29.54B(-5.6%) | $7.35B(+1.8%) | $29.57B(+0.2%) |
| Sep 2012 | - | $7.22B(-2.3%) | $29.52B(-2.8%) |
| Jun 2012 | - | $7.39B(-2.9%) | $30.37B(-2.9%) |
| Mar 2012 | - | $7.61B(+4.3%) | $31.29B(-0.3%) |
| Dec 2011 | $31.29B | $7.30B(-9.7%) | $31.38B(+0.1%) |
| Sep 2011 | - | $8.08B(-2.7%) | $31.34B(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $8.31B(+7.9%) | $30.92B(+0.9%) |
| Mar 2011 | - | $7.70B(+6.0%) | $30.63B(-2.1%) |
| Dec 2010 | $31.91B(-4.0%) | $7.26B(-5.1%) | $31.29B(-7.5%) |
| Sep 2010 | - | $7.65B(-4.5%) | $33.83B(-1.7%) |
| Jun 2010 | - | $8.02B(-4.2%) | $34.42B(-6.5%) |
| Mar 2010 | - | $8.36B(-14.7%) | $36.81B(+2.8%) |
| Dec 2009 | $33.26B(-1.3%) | $9.80B(+18.9%) | $35.80B(+3.7%) |
| Sep 2009 | - | $8.24B(-20.8%) | $34.53B(-5.4%) |
| Jun 2009 | - | $10.40B(+41.6%) | $36.50B(-1.8%) |
| Mar 2009 | - | $7.35B(-13.9%) | $37.17B(-3.6%) |
| Dec 2008 | $33.68B(-2.8%) | $8.53B(-16.5%) | $38.55B(-1.4%) |
| Sep 2008 | - | $10.22B(-7.7%) | $39.10B(+4.4%) |
| Jun 2008 | - | $11.07B(+27.0%) | $37.46B(+6.3%) |
| Mar 2008 | - | $8.72B(-4.0%) | $35.25B(+0.6%) |
| Dec 2007 | $34.65B(+3.3%) | $9.09B(+6.0%) | $35.05B(+1.3%) |
| Sep 2007 | - | $8.58B(-3.2%) | $34.60B(+0.8%) |
| Jun 2007 | - | $8.86B(+4.1%) | $34.31B(+1.3%) |
| Mar 2007 | - | $8.52B(-1.4%) | $33.86B(+0.9%) |
| Dec 2006 | $33.53B(+9.2%) | $8.64B(+4.3%) | $33.55B(+1.8%) |
| Sep 2006 | - | $8.29B(-1.5%) | $32.96B(+2.0%) |
| Jun 2006 | - | $8.42B(+2.6%) | $32.32B(+2.6%) |
| Mar 2006 | - | $8.20B(+1.8%) | $31.49B(+2.6%) |
| Dec 2005 | $30.70B(+7.3%) | $8.05B(+5.3%) | $30.68B(+1.6%) |
| Sep 2005 | - | $7.65B(+0.8%) | $30.20B(+2.5%) |
| Jun 2005 | - | $7.59B(+2.7%) | $29.45B(+1.7%) |
| Mar 2005 | - | $7.39B(-2.4%) | $28.96B(+1.3%) |
| Dec 2004 | $28.62B(+1.6%) | $7.57B(+9.6%) | $28.59B(+1.8%) |
| Sep 2004 | - | $6.91B(-2.6%) | $28.08B(-4.8%) |
| Jun 2004 | - | $7.09B(+1.0%) | $29.51B(+0.4%) |
| Mar 2004 | - | $7.02B(-0.6%) | $29.40B(+1.5%) |
| Dec 2003 | $28.17B(+10.6%) | $7.06B(-15.3%) | $28.97B(+0.4%) |
| Sep 2003 | - | $8.34B(+19.5%) | $28.84B(+8.7%) |
| Jun 2003 | - | $6.98B(+5.8%) | $26.53B(+2.6%) |
| Mar 2003 | - | $6.59B(-5.0%) | $25.85B(+3.6%) |
| Dec 2002 | $25.46B(+10.2%) | $6.94B(+15.1%) | $24.95B(+3.7%) |
| Sep 2002 | - | $6.03B(-4.2%) | $24.06B(+2.1%) |
| Jun 2002 | - | $6.29B(+10.5%) | $23.55B(+2.6%) |
| Mar 2002 | - | $5.69B(-5.8%) | $22.96B(+1.2%) |
| Dec 2001 | $23.12B(+7.1%) | $6.05B(+9.5%) | $22.68B(+1.8%) |
| Sep 2001 | - | $5.52B(-3.0%) | $22.27B(+1.7%) |
| Jun 2001 | - | $5.70B(+5.2%) | $21.90B(+1.5%) |
| Mar 2001 | - | $5.41B(-3.9%) | $21.58B(+1.1%) |
| Dec 2000 | $21.58B(+3.8%) | $5.63B(+9.3%) | $21.35B(+35.9%) |
| Sep 2000 | - | $5.15B(-4.2%) | $15.71B(+48.8%) |
| Jun 2000 | - | $5.38B(+3.9%) | $10.56B(+31.4%) |
| Mar 2000 | - | $5.18B(+81.2%) | $8.04B(+181.2%) |
| Dec 1999 | $20.80B(+106.4%) | - | - |
| Jun 1999 | - | $2.86B(+5.5%) | $2.86B(+5.5%) |
| Dec 1998 | $10.08B(+0.3%) | - | - |
| Jun 1998 | - | $2.71B | $2.71B |
| Dec 1997 | $10.05B(-0.4%) | - | - |
| Dec 1996 | $10.09B(+26.3%) | - | - |
| Dec 1995 | $7.99B(+22.1%) | - | - |
| Jun 1994 | $6.54B(+28.8%) | - | - |
| Jun 1993 | $5.08B(+7.5%) | - | - |
| Jun 1992 | $4.72B(+64.0%) | - | - |
| Jun 1991 | $2.88B | - | - |
FAQ
- What is GSK plc annual gross profit?
- What is the all time high annual gross profit for GSK plc?
- What is GSK plc annual gross profit year-on-year change?
- What is GSK plc quarterly gross profit?
- What is the all time high quarterly gross profit for GSK plc?
- What is GSK plc quarterly gross profit year-on-year change?
- What is GSK plc TTM gross profit?
- What is the all time high TTM gross profit for GSK plc?
- What is GSK plc TTM gross profit year-on-year change?
What is GSK plc annual gross profit?
The current annual gross profit of GSK is $27.98B
What is the all time high annual gross profit for GSK plc?
GSK plc all-time high annual gross profit is $34.65B
What is GSK plc annual gross profit year-on-year change?
Over the past year, GSK annual gross profit has changed by +$1.57B (+5.93%)
What is GSK plc quarterly gross profit?
The current quarterly gross profit of GSK is $7.78B
What is the all time high quarterly gross profit for GSK plc?
GSK plc all-time high quarterly gross profit is $11.07B
What is GSK plc quarterly gross profit year-on-year change?
Over the past year, GSK quarterly gross profit has changed by +$453.39M (+6.19%)
What is GSK plc TTM gross profit?
The current TTM gross profit of GSK is $29.36B
What is the all time high TTM gross profit for GSK plc?
GSK plc all-time high TTM gross profit is $39.10B
What is GSK plc TTM gross profit year-on-year change?
Over the past year, GSK TTM gross profit has changed by +$1.26B (+4.47%)